- An end to manufacturer rebates as we know them today?
By Deana Bell, Jennifer Carioto, Matthew Hayes | 15 February 2019
The proposed rule to make drug manufacturer rebates no longer protected under the Anti-Kickback Statute has broad impacts to federally funded prescription drug programs, especially Medicare Part D.
- Pathways to Success MSSP final rule: Winners and losers
By Anders Larson, Cory Gusland | 14 February 2019
This paper examines the Medicare Shared Savings Program’s (MSSP) final rule from the perspective of different accountable care organization (ACO) situations to help readers understand how the MSSP rule might affect different ACOs.
- Milliman Market Monitor London - 31 January 2019
By Neil Dissanayake, Peter Lin | 13 February 2019
European equity markets made strong gains in January, fully recovering from the slump in December, on the back of improving relationships between China and the US and signs of the Federal Reserve being more patient on raising interest rates.
- Student loans and regulation: A bumpy ride for borrowers
By Leighton A. Hunley, Katherine A. Pipkorn | 13 February 2019
Student loans now account for 10.7% of overall household debt, though a decade ago they accounted for less than 5%.
- Milliman VALUES 2018 GLWB industry lapse study
By Eileen S. Burns, Matthias Kullowatz, Jenny Jin, Ben Johnson, Vincent Haupt, Vincent Embser | 13 February 2019
The 2018 Milliman VALUES Guaranteed Lifetime Withdrawal Benefit (GLWB) industry lapse and utilization studies included 3 million policyholders from eight large variable annuity writers, representing roughly $350 billion of account value and covering a range of GLWB product designs as well as demographic attributes.
- LTSS services in Medicare Advantage Plans
By Pedro Alcocer, Robert Eaton, Pamela Laboy | 12 February 2019
This article addresses how the Medicare Advantage marketplace responded in 2019 to the Centers for Medicare and Medicaid Services’s expanded definition of primarily health-related benefits, including which supplemental benefits plans are offering and where these benefits are offered.
- Analysis of life insurers’ second set of Solvency and Financial Condition Reports: European and UK life insurers
By Neil Christy, Stuart Reynolds, William Smith | 12 February 2019
This analysis of the European life insurance market covers 600 companies from 31 countries and one territory, representing approximately £612 billion (€691 billion) of Gross Written Premium and approximately £6,508 billion (€7,302 billion) of gross Technical Provisions.
- Industry body part coding is wrong - Part 1: Multiple body parts
By Michael Paczolt, William Torres | 11 February 2019
Multiple body part claims can be translated into specific combinations of body parts by extracting data from unstructured data using text mining algorithms.
- Analysis of Belgian insurers’ Solvency and Financial Condition Reports: Year-end 2017
By Nicholas Batens, Peter Franken, Wouter van Goudoever, Kurt Lambrechts, Moussa Ouédraogo, Rens IJsendijk | 11 February 2019
This report provides a summary of Solvency and Financial Condition Reports and the main players in the Belgian market for both life and non-life undertakings.
- Including dementia in the Part C Medicare risk adjuster: Health services issues
By Bruce S. Pyenson, Charles Steffens | 11 February 2019
The Centers for Medicare and Medicaid Services released its proposed 2020 risk score methodology for Medicare Advantage plans in December, and it describes proposed updates to the existing Hierarchical Condition Category (HCC) risk adjustment model and suggests an alternative model, which includes two HCCs for dementia.